Clinical Trials Browser

Phase 2/3 × INDUSTRY × remimazolam × Clear all

NCT04851717 2025-07-01

Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures

Phase 2/3 Active not recruiting

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma